111in - pentreotide SPECT/CT, 18F-DOPA PET/CT和68Ga-HA-DOTATATE PET/CT显示胃肠道神经内分泌肿瘤伴不一致转移。

IF 1.7 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

European Journal of Hybrid Imaging Pub Date : 2022-07-04 DOI:10.1186/s41824-022-00134-5

Katrin Resch, Ryan Hung, Jonathan Abele

{"title":"111in - pentreotide SPECT/CT, 18F-DOPA PET/CT和68Ga-HA-DOTATATE PET/CT显示胃肠道神经内分泌肿瘤伴不一致转移。","authors":"Katrin Resch, Ryan Hung, Jonathan Abele","doi":"10.1186/s41824-022-00134-5","DOIUrl":null,"url":null,"abstract":"A 62-year-old man with resected, pathology-proven small bowel neuroendocrine tumor underwent 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT to assess metastatic disease. The 111In-pentetreotide SPECT/CT scan showed no metastatic disease. Both 18F-DOPA and 68Ga-HA-DOTATATE PET/CT showed hepatic and peritoneal metastatic disease. However, the burden of 18F-DOPA-avid metastatic disease was far greater compared to the burden of 68Ga-HA-DOTATATE-avid metastatic disease.","PeriodicalId":36160,"journal":{"name":"European Journal of Hybrid Imaging","volume":" ","pages":"13"},"PeriodicalIF":1.7000,"publicationDate":"2022-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250908/pdf/","citationCount":"0","resultStr":"{\"title\":\"Gastrointestinal neuroendocrine tumor with discordant metastatic disease on 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT.\",\"authors\":\"Katrin Resch, Ryan Hung, Jonathan Abele\",\"doi\":\"10.1186/s41824-022-00134-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A 62-year-old man with resected, pathology-proven small bowel neuroendocrine tumor underwent 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT to assess metastatic disease. The 111In-pentetreotide SPECT/CT scan showed no metastatic disease. Both 18F-DOPA and 68Ga-HA-DOTATATE PET/CT showed hepatic and peritoneal metastatic disease. However, the burden of 18F-DOPA-avid metastatic disease was far greater compared to the burden of 68Ga-HA-DOTATATE-avid metastatic disease.\",\"PeriodicalId\":36160,\"journal\":{\"name\":\"European Journal of Hybrid Imaging\",\"volume\":\" \",\"pages\":\"13\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2022-07-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250908/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Hybrid Imaging\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s41824-022-00134-5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Hybrid Imaging","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s41824-022-00134-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}

引用次数: 0

摘要

一名62岁的小肠神经内分泌肿瘤切除患者接受111in - pentreotide SPECT/CT、18F-DOPA PET/CT和68Ga-HA-DOTATATE PET/CT评估转移性疾病。111in -戊肽SPECT/CT扫描未见转移性疾病。18F-DOPA和68Ga-HA-DOTATATE PET/CT均显示肝脏和腹膜转移性疾病。然而，与68ga - ha - dotate -avid转移性疾病相比，18F-DOPA-avid转移性疾病的负担要大得多。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Gastrointestinal neuroendocrine tumor with discordant metastatic disease on 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT.

查看原文本刊更多论文

Gastrointestinal neuroendocrine tumor with discordant metastatic disease on 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT.

A 62-year-old man with resected, pathology-proven small bowel neuroendocrine tumor underwent 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT to assess metastatic disease. The 111In-pentetreotide SPECT/CT scan showed no metastatic disease. Both 18F-DOPA and 68Ga-HA-DOTATATE PET/CT showed hepatic and peritoneal metastatic disease. However, the burden of 18F-DOPA-avid metastatic disease was far greater compared to the burden of 68Ga-HA-DOTATATE-avid metastatic disease.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European Journal of Hybrid Imaging Computer Science-Computer Science (miscellaneous)

CiteScore

3.40

自引率

0.00%

发文量

审稿时长

17 weeks